Windlas Biotech

Windlas Biotech EBITDA per Share

The EBITDA per Share of Windlas Biotech (WINDLAS.NS) as of Oct 17, 2026 is 37.15 INR. In the previous year, EBITDA per Share was 52.69 INR — a change of -29.49% (lower).

EBITDA per Share

37.15INR

YoY

-29.49%

Last updated:

EBITDA per Share of Windlas Biotech is 2026 37.15 INR. EBITDA per Share of Windlas Biotech was 2025 52.69 INR. It decreases by -29.49% lower compared to the previous year.

The Windlas Biotech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
16.16 INR
Jan 1, 2020
22.98 INR
Jan 1, 2021
25.84 INR
Jan 1, 2022
27.22 INR
Jan 1, 2023
33.75 INR
Jan 1, 2024
43.42 INR
Jan 1, 2025
52.69 INR
Jan 1, 2026
37.15 INR
The Windlas Biotech EBITDA per Share history
YEAREBITDA per ShareYoY
37.15INR-29.49%
52.69INR+21.36%
43.42INR+28.64%
33.75INR+23.98%
27.22INR+5.36%
25.84INR+12.45%
22.98INR+42.15%
16.16INR+52.60%
10.59INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Windlas Biotech Stock analysis

What does Windlas Biotech do? Windlas Biotech Ltd is a contract development and manufacturing organization based in Dehradun, Uttarakhand, India. Listed on the National Stock Exchange with ticker WINDLAS.NS, the company employs 1,049 full-time staff. It provides comprehensive CDMO services, including product discovery, development, licensing, and commercial manufacturing of generic products, with a focus on complex generics. The firm specializes in therapeutic areas such as anti-diabetic, cardiovascular, neuropsychiatry, and respiratory treatments. Its capabilities cover formulation development, technology scale-up, and full-scale commercial manufacturing for both solid and liquid pharmaceutical dosage forms. Beyond contract services, Windlas markets its own nutraceutical, pharmaceutical, and Ayurvedic products to semi-urban and rural communities through a salesforce and distribution network spanning over 14 states. The company conducted its initial public offering on August 16, 2021. Windlas Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Windlas Biotech stock

EBITDA per Share of Windlas Biotech is 37.15 INR in 2026.

EBITDA per Share of Windlas Biotech changed from 52.69 INR to 37.15 INR, representing a -29.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Windlas Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Windlas Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Windlas Biotech